Letter Development and implementation of a national antimicrobial intravenous-to-oral switch criteria for early switchingPublished: 3 February 2023
Letter Appropriate management of urinary tract infections in older patientsPublished: 30 December 2022
Letter Transitional change is required to reposition pharmacy as we enter 2023Published: 29 December 2022
Letter Public and pharmacist views on the appearance of and messaging on antibiotics to address inappropriate usePublished: 28 December 2022
Letter Highlights of 2022: a letter from the three Royal Pharmaceutical Society national pharmacy board chairsPublished: 23 December 2022
Letter Evaluation of the first private community hospital provider delivering the discharge medicines service in EnglandPublished: 22 December 2022
Letter The Manchester Pharmaceutical Association is winding up after more than 150 yearsPublished: 5 December 2022
Letter How trainee pharmacists are tackling AMR through a schools outreach schemePublished: 24 November 2022
Letter Treatment with transdermal unlicensed medication for complex regional pain syndrome — is there enough evidence?Published: 23 November 2022
